← Back to Search

Home Exercise Program for Metabolic Syndrome

N/A
Recruiting
Led By Dmitry Rozenberg, MD PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult lung and liver transplant recipients 12 to 18 months post-transplant
Presence of 2 or more metabolic risk factors (hypertension, hyperlipidemia, diabetes, obesity)
Must not have
Neuro-muscular disease or orthopedic limitations
Active cardiovascular disease (recent heart attack, significant coronary artery disease on cardiac catheterization, heart failure, uncontrolled arrhythmias, chest pain, dizziness, or fainting in the last 3 months)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Summary

This trial is testing the feasibility and efficacy of a home-based exercise program for people who have had a liver or lung transplant and are at risk for post-transplant metabolic syndrome.

Who is the study for?
This trial is for adult lung and liver transplant recipients who are 12 to 18 months post-transplant with at least two metabolic risk factors like high blood pressure, high cholesterol, diabetes, or obesity. It's not for those with neuro-muscular diseases, orthopedic limitations, already very active individuals, people living outside Ontario or those with recent serious heart issues.
What is being tested?
The study tests a three-month home-based exercise program's feasibility and its impact on Post-transplant Metabolic Syndrome (PTMS). Participants will do aerobic exercises several times a week plus resistance training twice weekly. They'll get guidance from an exercise professional through phone and video calls.
What are the potential side effects?
Since the intervention involves regular exercise training designed by professionals according to individual capabilities, significant side effects are not expected. However, participants may experience typical workout-related discomforts such as muscle soreness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a lung or liver transplant 1 to 1.5 years ago.
Select...
I have two or more conditions like high blood pressure, high cholesterol, diabetes, or obesity.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a muscle or bone condition that limits my movement.
Select...
I have had serious heart problems or symptoms in the last 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 2, 6, and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 2, 6, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to Exercise Training
Adverse Events During Exercise Training (Safety and Tolerability)
Participant Satisfaction with Exercise Training and Study Participation (Exercise Group)
+3 more
Secondary study objectives
C-peptide Levels
C-reactive Protein Levels
Fasting Blood Glucose Levels
+13 more
Other study objectives
Body Fat Mass Index
Electrocardiogram
Fat Free Mass Index
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Home Exercise GroupExperimental Treatment1 Intervention
The home-based exercise group will be asked to exercise 3 to 5 times per week (≥ 150 minutes of aerobic exercises (i.e. walking, cycling, or treadmill) of at least moderate intensity) and to also complete resistance training (resistance bands or free weights) at least twice weekly over a 12-week period supervised by an exercise professional. The resistance training will be personalized, aiming for 6 to 10 exercises targeting the major muscle groups, progressing to 3 sets of 8 to 12 repetitions. Exercise prescriptions will be developed and monitored by an exercise professional with weekly follow-up meetings and supported with a web application (Physiotec) that allows customizable exercise prescriptions, tracking of exercise completion, and video tutorials. Participants will receive one counselling session on healthy eating and physical activity at the start of the study along with an exercise manual.
Group II: Control GroupActive Control1 Intervention
Participants will receive one counselling session on healthy eating and physical activity at the start of the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise Training
2011
Completed Phase 3
~1470

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,514 Previous Clinical Trials
500,165 Total Patients Enrolled
4 Trials studying Metabolic Syndrome
167 Patients Enrolled for Metabolic Syndrome
Canadian National Transplant Research ProgramOTHER
8 Previous Clinical Trials
1,540 Total Patients Enrolled
University of TorontoOTHER
705 Previous Clinical Trials
1,021,511 Total Patients Enrolled
22 Trials studying Metabolic Syndrome
918 Patients Enrolled for Metabolic Syndrome
~10 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top